Join us for an exciting conference on Point of Care Diagnostics (POCD) and the latest trends and innovations in Point of Care Testing (POCT) and diagnostic technologies. POCT has gained significant traction worldwide, with an increasing demand for it, leading to a shift of care from hospitals to communities. Novel diagnostic technologies have the potential to reduce costs and improve speed, quality and access, so patients in remote or resource-limited areas can receive reliable diagnostic tests.
While cures for viral diseases such as COVID-19 are challenging, detection and surveillance are key to reducing their spread. The rapid spread of COVID-19 test kits in the community has demonstrated the potential and impressive scalability of rapid POCT diagnostics. The range of applications is vast andthis event, we will discuss barriers and opportunities for POCT in our challenges such as traceability, accountability, accuracy and risks in test This full-day event will feature a broad range of topics: how to bring products to market, market trends and opportunities, manufacturing capabilities, emerging wearables and other innovations, product development programs, commercial success and de-risking the pathway to market.We will also explore the impact of CRISPR on POCT, designing diagnostics with the end user in mind, connectivity, cyber security, and the implications for patients and healthcare.Don’t miss this opportunity to learn about the latest developments in POCT and the future of diagnostic technologies.Join us and be informed!
SESSION 1: Exploring Manufacturing Capabilities and Market DemandThe opening session will address manufacturing capabilities and market demand in point of care diagnostics in Australia. Our speakers will discuss challenges and opportunities developing and scaling manufacturing processes for point of care diagnostics, getting a product through regulations and opportunities for device developers. We will also discuss development of the National Action Plan for establishing end-to-end sovereign manufacturing capability for diagnostic products in Australia.SESSION 2: Cutting-edge Technologies and Next-gen InnovationsThis session will showcase exciting cutting-edge technologies and next-gen innovations on the horizon for the point of care diagnostics industry. Our speakers will highlight the latest advancements in the field, including wearable diagnostics, CRISPR-based detection platforms – and more. They will also discuss how the latest innovations in this space may impact the sector.SESSION 3: Navigating Product Development and Commercialisation: Insights from IndustryThis session will explore product development and commercialisation challenges for the point of care diagnostics industry. Our speakers will discuss the product development process, growth opportunities, and de-risking translation and development for commercial success. You will also hear about issues faced by the sector and the impacts for manufacturing and the talent pool in Australia.SESSION 4: Designing Diagnostics with the End User in MindThe final session will discuss designing diagnostics with the end user in mind. Our speakers will explore patient-centred design principles and requirements, and how good patient-centred product design can improve patient outcomes and ensure commercial success. You will also hear about the latest product design trends in the industry.
This is a must-attend event for:
We strongly recommend those in the following fields to participate:
We welcome all:
Date: Thursday 27 April 2023
8:15am – Registration, tea, coffee and networking
8:45am – 5:30pm – Session 1 – 4 (Live streamed)
5:30pm – 6:30pm – Networking
Format: Hybrid – In-Person and online
Venue: International Chamber House, Theatrette, Level 5, 121 Exhibition Street, Melbourne 3000
Host: Jeff Malone, CEO, BioMelbourne Network
In-person: Member $400; Non-Member $690
Online: Member $50; Non-Member $120
More details to come.